FDA Warns J&J Unit Over Joint Product Marketing
In a letter to DePuy dated Aug. 19 and widely reported Tuesday, the FDA claims that the company's Corail Hip System is being marketed in the U.S. for off-label uses.
The letter from Timothy A. Ulatowski, director of the FDA's compliance office for the Center for Devices and Radiological Health, orders DePuy to immediately stop...
Already a subscriber? Click here to login